Search


OB-GYN UH Sites WWW

About The Program

Quick Links

Emeritus Professors


Ralph Hale, M.D.
  • Ralph W. Hale, M.D., History Museum, located at American College of Obstetricians and Gynecologists (ACOG), Washington, D.C.  (Collection of artifacts related to Obstetrics and Gynecology), dedication on February 2008
  • Chair, U.S. Anti-Doping Agency Board of Directors, since 2003
  • Vice-Chair, U.S. Anti-Doping Agency Board of Directors (2000-2003)
  • Executive Vice President, American College of Obstetricians and Gynecologists (ACOG), Washington, D.C.
  • Former Chair, John A. Burns School of Medicine, Department of Obstetrics & Gynecology
  • Former Associate Dean of Clinical and Student Affairs, University of Hawaii
  • Past President of the Association of Professor of Gynecology and Obstetrics (1990-1991) and Past President of the Pacific Coast Fertility Society (1980-1981)
  • Former Vice President, U.S. Olympic Committee (1992-1996)
  • Served as Vice Chair, USOC Sports Medicine Committee and member of several other USOC committees
  • Expert on exercise and women and published many journal articles, abstracts and books on the subject
  • Served in numerous appointed positions for U.S. sports groups, including the United States Aquatic Sports, Amateur Swimming Union of Americas and U.S. Water Polo
  • Member of the U.S. delegation staff at four Olympic Games (1998, 1992, 1994, and 1996), including serving as the United States' Chef de Mission for the Atlanta Olympic Games
  • Residency- Akron, Ohio and Kapiolani Medical Center, Honolulu, Hawaii
  • M.D.- University of Illinois at Chicago
  • Undergraduate-University of Illinois at Urbana-Champaign

Thomas Kosasa, M.D.
  • Board Certification: American Board of Obstetrics and Gynecology
  • Chief, Reproductive Endocrinology Division, John A. Burns School of Medicine, Honolulu, Hawaii
  • Co-Director, Pacific In Vitro Fertilization Institute
  • Board of Medical Examiners for the State of Hawaii
  • Member, American Fertility Society; Pacific Coast Fertility Society; Hawaii Medical Association; Board of Trustees, Pan Pacific Surgical Association
  • Fellow, American College of Obstetricians and Gynecologists
  • Consultant, Advisory Committee for Reproductive Health Drugs for the FDA Center for Drug Evaluation and Research
  • Food and Drug Administration Committee for Maternal and Reproductive Health
  • Chair, Reproductive Endocrinology Division, John A. Burns School of Medicine, Honolulu, Hawaii
  • Published over 50 scientific articles in the field of Reproductive Endocrinology, Obstetrics and Gynecology
  • Awards:
    • 2009 University of Hawaii, John A. Burns School of Medicine Excellence in Teaching Award
    • 2006 Golden Speculum Award
    • September 7, 2006 The Kenneth Brown Health Award
  • Background:
    • Fellowship: Peter Bent Brigham Hospital, Harvard Medical School,Reproductive Endocrinology, Boston, MA
    • Residency: Boston Hospital for Women, Harvard Medical School, Boston, MA
    • Internship: Royal Victoria Hospital, McGill University Medical School, Montreal Canada
    • Medical School: Dartmouth Medical School, Hanover NH;McGill University Medical School, Montreal, Canada
    • Undergraduate: Dartmouth College, Hanover, NH
  • Peer Reviewed Publications:
    • Kosasa TS. The Role of Metformin in Polycystic Ovary Syndrome. Cont OB-GYN 2003;48:69-80.

Santosh Sharma, M.D.
  • Board Certification: American Board of Obstetrics and Gynecology
  • Fully licensed/registered in Hawaii, Maryland, Uganda, England, India
  • Fellow, Royal College of Obstetricians and Gynecologists; Gynecologic Laser Society
  • Member, North American Menopause Society; multiple Institutional Review Boards; Tenure and Promotion Review Committee; Admissions Committee, UH, JABSOM
  • Recipient: Colposcopy Merit Award, American Society of Colposcopy and Cervical Pathology; International Federation of Gynecology & Obstetrics 1994 "Lifetime Contribution Towards Improvement of Women’s Health" Award
  • Recognized authority on Colposcopy and Cervical Pathology, Menopause and Hormone Replacement Therapy
  • Co-Investigator or Principal Investigator of numerous grants
  • Background
    • Residency: various hospitals in England
    • Medical School: Poona University, India
  • Research Interests:
    • Menopause
    • Colposcopy
    • HPV Disease
    • Racial Ethnic Disparities in Birth Weights
  • Publications
    • SHARMA, S.D.; JONES, G.: Amniography - A Useful Procedure in Antenatal Care in East Africa, E. Afr. Med. J., Vol. 47, January 1970.
    • SHARMA, S.D.; TRUSSELL, R.R.: The Value of Amniotic Fluid Examination in the Assessment of Fetal Maturity, J. of Obstet. & Gynec., British Commonwealth, 77:215, March 1970.
    • SHARMA, S.D.; ZIEGLER, 0.; TRUSSELL, R.R.: A Case of Schistosomiasis Haematobium of the Cervix, Acta Cytologica, 14(6) :305, 1970.
    • SHARMA, S.D.; ZIEGLER, 0.; Trussell, R.R.: A Cytologic Study of Dipetalonema Perstans in Cervical Smears, Acta Cytologica, 15(5) :479, 1971.
    • KARIM, S.M.M.; SHARMA, S.D.: The Effect of Ethyl Alcohol on Prostaglandins E2 and F2 for the Induction of Labor, Brit.med. J., 1:260, Jan., 1971
    • KARIM, S.M.M.; SHARMA, S.D.: Therapeutic Abortion and Induction of Labor with Intravaginal Administration of Prostaglandins E2 and F2, J. of Obstet. & Gynec., British Commonwealth, 78-294-300, April 1971
    • KARIM, S.M.M.; SHARMA, S.D.: Two Years Experience with Prostaglandins E2 for Induction of Labor, J. Asian Federation of Obstet. & Gynec., 2:1-6, 1971.
    • ADAM, E.; SHARMA, S.D.; ZIEGLER, 0.; IWANOTO, K.; MELNICK,J.L.; LEVY, A.H.; RAWLS, W.E.:Seroepidemiologic Studies of
      Herpes Virus Type 2 and Carcinoma of the Cervix, II. Uganda,Journal of National Cancer Institute, 28(1) :65-72, January 1972.
    • KARIM, S.M.M.; SHARMA, S.D.: Second Trimester Abortion with Single Intra-amniotic Injection of Prostaglandins E2 and F2, The Lancet, July 3, 1971.
    • SHARMA, S.D.; MODY, N.J.: Immunity to Malaria During Pregnancy, E. Afr. Med. J., 1972.
    • KARIM, S.M.M.; SHARMA, S.D.: Oral Administration of Prostaglandin E2 for the Induction and Acceleration of Labor, J. Reproductive Med. 9(6) :346, December 1972.
    • KARIM, S.M.M.; SHARMA, S.D.: Termination of Second Trimester Pregnancy with Intra-amniotic Administration of Prostaglandins E2 and F2, J. Reproductive Med., 9:427, December 1972.
    • KARIM, S.M.M.; SHARMA, S.D.: Termination of Second Trimester Pregnancy with 15 methyl Analogues of Prostaglandins E2 and F2, J. of Obstet. & Gynec., British Commonwealth, 79:737, August 1972.
    • KARIM, S.M.M.; SHARMA, S.D.: Termination of Pregnancy with 15 methyl Analogues of Prostaglandins E2 and F2, J.Reproductive Med., 9(6):383, December 1972
    • KARIM, S.M.M.; SHARMA, S.D.; FILSHIE, G.M.; SALMON, J.A.;GANESA, A.: Termination of Pregnancy with Prostaglandin Analogues, Advances in Biosciences,, 9 - InternationalConference of Prostaglandins, edited by S. Bergstrom and S.Bernhard, Press-Viewing Oxford, p. 811-830, 1973.
    • LEIGHTON, P.C.; ZIEGLER, 0.; TRUSSELL, R.R.; SHARMA, S.D.:The Organization of Diagnostic Cervical Cytology Services in Uganda, Tropical Doctor, 5(2) :79, 1975.
    • HERSON, J.; SHARMA, S.D.; CROCKER, C. L.; JONES, D.:Physical Complaints of Patients with Sickle Cell Trait, J.Reproductive Med., 14(3) :129, 1975.
    • SHARMA, S.D.; HALE, R.W.: Early Mid-Trimester Abortion - By Intramuscular 15 methyl Prostaglandin E2, Prostaglandins, 8(2): 171, ‘1974.
    • SHARMA, S.D.; HALE, R.W.; SATO, N.E.: Intramuscular Administration of (15S) - 15 methyl Prostaglandin F2 for Termination of Mid-trimester Pregnancies and Missed Abortions, Obstet. & Gynec., 46:468, 1975.
    • SHARMA, S.D.; HALE, R.W.: First Trimester Abortion Using Intramuscular (15S) - 15 methyl Prostaglandin F2, Contraception, 12:445, 1976.
    • SHARMA, S.D.: Induction of Labor at Term with Prostaglandin F2, Prostaglandins and Therapeutics, 2(4) :3, 1977.
    • TSUEI, J.J.; SHARMA, S.D.; LAI, YIN-Fun:The Influence of Acupuncture Stimulation During Pregnancy - The Induction and Inhibition of Labor, Obstet. & Gynec., March 1977.
    • CROWELL, D.H.; SHARMA, S.D.; PHILIP, A.G.S.; KAPUNIAI, L.E.; WAXMAN, S.H.; HALE, R.W.: The Effects of Induction of Labor
      on the Neurophysiological Function of Newborns, Am J. Obstet.Gynec., Vol. 136, No. 1, p. 48, 1980.
    • LEIGHTON, P.C.; ZIEGLER, 0.; TRUSSELL, R. R.; SHARMA, S.D.:Exfoliative Cervical Cytology in Uganda, Acta Cytologica, 17:263, 1973.
    • SHARMA, S.D.; HALE, R.W.: First Trimester Abortion Using Intramuscular (15S) - 15 methyl Prostaglandin F2, Advances in Prostaglandin and Thromboxane Research, p. 989.
    • SHARMA, S.D.: Cancer of the Cervix. Chapter 21, A Concise Textbook of Gynecology, edited by Drs. Hale and Krieger.Medical Examination Publishing Co., Inc., 1982.
    • SHARMA, S.D.: Abortion. Chapter 9, A Concise Textbook of Gynecology, edited by Drs. Hale and Krieger. Medical Examination Publishing Co., Inc. 1982.
    • HALE, R.W.; SHARMA, S.D.: The Breast. Chapter 27, A Concise Textbook of Gynecology, edited by Drs. Hale and Krieger.Medical Examination Publishing Co., Inc., 1982.
    • SHARMA, S.D.; STEINMILLER, V.; HALE, R.D.: Intramuscular Administration of 15-Methyl Prostaglandin F2 and Laminaria Insertion for Termination of Midtrimester Pregnancy. Prostaglandin and Fertility Regulation, MTP Press Ltd., 1984.
    • SHARMA, S..: Chapter 6: Maternal Physiology in Pregnancy:General Consideration, Concise Textbook of Obstetrics, edited by Drs. Hale and Krieger. Medical Examination Publishing Co., Inc. 1987.
    • SHARMA, S.D.: Chapter 7: Maternal Physiology in pregnancy:Systemic Changes. Concise Textbook of Obstetrics, edited by Drs. Hale and Krieger. Medical Examination Publishing Co., Inc., 1987.
    • CROWELL, D.; McGEE, R.I.; SETO, D.; SHARMA, S.D.; DUNN¬RANKIN, P.: Race, Ethnicity and Birth-Weight: Hawaii 1983 to 1986. Hawaii Medical Journal, 51(9):242-255, September 1992.
    • CROWELL, D.H.; McGEE, R.I; SETO, D.; SHARMA, S.; DtINN-RANKIN,P.; HORIUCHI, B.: Parental Ethnicity and Human Intrauterine
      Growth, Proceedings of the Symposium on Peripartal Health Problems in Minority Women, p. 71-19, edited by Marilyn F.Dunlap, National Institutes of Health, 1995.
    • Contributor: HRT Which Regimen for which Patient? OBG Management, 59-70, October 1997.
    • GOODMAN, M.; KIAVIT, N.; McDUFFIE, K.; HANKIN, J.; HERNANDEZ, B.; WILKENS, L.; FRANKE, A.; KUYPERS, J.; KOLONEL, L.;
      NAKAMURA, J.; ING, G.; BRANCH, B.; BERTRAM, C.; KAMEMOTO, L.;SHARMA, S.; KILLEEN, J.: The Association of Plasma
      Micronutrients with the Risk of Cervical Dysplasia in Hawaii,Cancer Epidemiology, Biomarkers & Prevention,7:537-44, June 1998.
    • WAKABAYASHI, M.; TRETIAK, M.; KOSASA, T.; SHARMA, S.; AEBY, T.; KAMEMOTO, L.; DINIEGA, L.: Intravaginal Misoprostol for medical evacuation of first trimester missed abortion, Primary Care Update for Ob/Gyns, Vol. 5, 4:176, June 1998.
    • Contributor: HRT and Heart Health: What the Experts Are Doing Now. OBG Management, 88-97, June 2000.
  • Grants
    • Co-investigator, Women’s Health Initiative Study, NIH Grant, 1994-2005 ($9,297,062.00)
    • Principal Investigator: Immunogenecity and safety of Quadrivalent HPV (Types 6, 11, 16, 18) Virus like particles (VLP) in 16-23 years old women. Multicenter trial supported by MERCK & Co. (Hawai`i Pacific Health Research Institute). 2002 - 2006
    • Co-investigator, A double Blind Randomized Study of the efficacy of an HPV-16/18 VLP Vaccine in the Prevention of persistent HPV-16 or HPV-18 cervical Infection and Advanced Cervical Neoplasia.